Drug Information

Drug General Information
Drug ID
D01VMZ
Former ID
DCL001149
Drug Name
ARI-3037MO
Indication Dyslipidaemias [ICD9: 272; ICD10:E78] Phase 1 [550270]
Company
Arisaph Pharmaceuticals
Target and Pathway
Target(s) Diacylglycerol O-acyltransferase 2 Target Info Inhibitor [550270]
G protein-coupled receptor 110A niacin receptor Target Info Agonist [550270]
BioCyc Pathway Triacylglycerol biosynthesis
KEGG Pathway Glycerolipid metabolism
Metabolic pathways
Fat digestion and absorption
Reactome Acyl chain remodeling of DAG and TAG
Triglyceride Biosynthesis
WikiPathways Triacylglyceride Synthesis
Glycerophospholipid biosynthesis
Fatty acid, triacylglycerol, and ketone body metabolism
References
Ref 5502702011 Pipeline of Arisaph Pharmaceuticals.
Ref 5502702011 Pipeline of Arisaph Pharmaceuticals.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.